NEXLIZET Prescribing Information
NEXLETOL Prescribing Information

Access to NEXLIZET® or NEXLETOL® is easier than ever. With expanded access through major payers—Medicare/government, UnitedHealthcare, Cigna, Aetna, and more—patients have the potential to benefit from these options.

Explore the information below to discover how you can help improve access for your patients by staying updated on the latest payer information.

Nicole A. Ciffone MS, ANP-C, AACC, FNLA
NEXLIZET® (bempedoic acid/ezetimibe) 180mg/10mg tablets | NEXLETOL® (bempedoic acid) 180mg tablets
Exciting news!
Accessing NEXLETOL® and
NEXLIZET® has never been easier!
The following payers now provide expanded coverage for the NEXLIZET and NEXLETOL indications:
Medicare/Government
UnitedHealthcare/AARP
Express Scripts
Cigna
SilverScript
Aetna
TRICARE
Commercial
UnitedHealthcare
Express Scripts
Cigna
CVS/Caremark
Navitus Health Solutions
Aetna
Prior authorization may be required. All payers are not listed.
Have you seen the latest patient access and coverage information for NEXLIZET and NEXLETOL?
LEARN MORE
ESPERION®
Contact Us  Privacy Policy  Terms of Use

This information is intended only for healthcare professionals in the United States.

All trademarks and trade names are the property of their respective owners.
© 2025 Esperion Therapeutics, Inc. All rights reserved. US‑NXNZ-2500041